This study compared the effects of selective and mixed-action KOR and DOR agonists to the effects of a positive-control analgesic (hydrocodone) and a negative-control non-analgesic (aprepitant) in a recently validated assay of pain-related behavioral depression in mice. The gene discussed is OPRK1; the disease is depressive symptom measurement.